Cited by 33COVID-19 Clinical Research StudiesRespiratory Support and MechanismsLong-Term Effects of COVID-19

Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study

Open access
Kader, Manzur, Hossain, Md. Afzal, Reddy, Vijayendar, Perera, Nirmala K. Panagodage, Rashid, Mamunur·2022·BMC Sports Science, Medicine and Rehabilitation

Published version of a preprint

Abstract

Background: Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory tract disease. The most common clinical manifestation of severe COVID-19 is acute respiratory failure. Respiratory rehabilitation can be a crucial part of treatment, but data lack for patients with COVID-19. This study investigates the effects of short-term respiratory rehabilitation (i.e., breathing exercises) on respiratory recovery among non-ICU hospitalised patients with COVID-19. Methods: This was a quasi-experimental, pre-and post-test study. The study recruited 173 patients hospitalised with moderate to severe COVID-19. All the patients received standardised care for COVID-19, and 94 patients in the intervention group also received the intervention of breathing exercises, which included breathing control, followed by diaphragmatic breathing, deep breathing, or thoracic expansion exercise, and huffing (forced expiratory technique) and coughing. Data on the mean values of peripheral oxygen saturation (SpO 2 ), need for oxygen therapy (litre/min), respiratory rate (breaths/minute), and heart rate (beats/minute) and were collected at baseline, 4 days, and 7 days after the baseline assessment. Analysis of variance on repeated measures was applied to compare the mean value of outcome measures of all the time points. Results: The mean (± SD) age of the intervention (69.6% men) and control group (62.1% men) were 50.1 (10.5) and 51.5 (10.4) years, respectively. At 4-day of follow-up, SpO2 (96.6% ± 1.9 vs. 90.7% ± 1.8, P < 0.001), need for oxygen therapy (0.8 ± 2.6 vs. 2.3 ± 2.9, P < 0.001), respiratory rate (20.5 ± 2.3 vs. 22.3 ± 2.5, P < 0.001), and heart rate (81.2 ± 9.5 vs. 89.2 ± 8.9, P < 0.001) improved in the intervention group compared to the control group. At 7-day follow-up, differences remained significant concerning the oxygen saturation and the need for oxygen therapy ( P < 0.001) between the groups. Conclusions: Our results indicate that breathing exercise, even for a short period, effectively improves specific respiratory parameters in moderate to severe COVID-19 patients. As a non-invasive and cost-effective respiratory rehabilitation intervention, breathing exercise can be a valuable tool for a health care system overwhelmed by the COVID-19 pandemic. These results should be considered preliminary until they are replicated in larger samples in different settings.

AI snapshot

Written from the paper’s full text.

TL;DR

In non-ICU hospitalised patients with moderate to severe COVID-19, adding short-term supervised breathing exercises to standardised care improved oxygen saturation, oxygen need, respiratory rate, and heart rate at 4 days compared with standard care alone. At 7 days, only oxygen saturation and oxygen need remained significantly better in the intervention group.

Key findings

  • At 4 days, intervention vs control: SpO2 96.6% ± 1.9 vs 90.7% ± 1.8; oxygen need 0.81 ± 2.6 vs 2.3 ± 2.9 L/min; respiratory rate 20.5 ± 2.3 vs 22.3 ± 2.5 breaths/min; heart rate 81.2 ± 9.5 vs 89.2 ± 8.9 beats/min; all P < 0.001.
  • At 7 days, SpO2 and oxygen need remained significantly different between groups (P < 0.001), while respiratory rate (P = 0.09) and heart rate (P = 0.47) did not.
  • Baseline outcome values did not differ significantly between groups (P > 0.05); baseline characteristics were comparable except total WBC count was higher in the intervention group (P = 0.04).
  • The authors conclude that breathing exercise, even for a short period, effectively improves specific respiratory parameters in moderate to severe COVID-19, but results should be considered preliminary until replicated in larger samples in different settings.

Methods

  • Quasi-experimental pre-and post-test study in non-ICU hospitalised adults with laboratory-confirmed COVID-19 and moderate-to-severe respiratory symptoms (SpO2 < 93%, oxygen supplementation < 10 L/min), aged 18–70 years, recruited from tertiary hospitals in Bangladesh; 94 patients were allocated to the intervention group and 79 to the control group, with 79 vs 58 analysed at 4 days and 64 vs 50 at 7 days.
  • The intervention group received standardised care plus supervised breathing exercises (breathing control, diaphragmatic breathing, deep breathing or thoracic expansion, and huffing and coughing), around 15-minute sessions, about seven sessions per day, with prone positioning; the control group received standardised care only.
  • Outcomes (SpO2, need for oxygen therapy in L/min, respiratory rate, heart rate) were measured at baseline, 4 days, and 7 days; analysis used repeated-measures ANOVA with Bonferroni adjustment, paired t-tests, independent t-tests/chi-square tests, and SPSS v26; a priori power analysis indicated 108 participants for 80% power.

Limitations

  • Stated: the quasi-experimental design lacked random assignment, so other differences between groups are likely; only short-term 4- and 7-day effects were evaluated; no specific information was collected on the number of interventions between 5 and 7 days because the intervention was tailored or reduced based on patient needs; results are preliminary until replicated in larger samples in different settings.
  • Stated: the intervention group came from one hospital and the control group from three other hospitals, so resource availability might differ between hospitals, although standardised care and a standard data-collection protocol were used.
  • Evident from the text: loss to follow-up and missing outcome data (173 allocated but 137 analysed at 4 days and 114 at 7 days; respiratory rate missing n = 10/12 in the intervention group and n = 7/9 in the control group at baseline/4-day) may affect interpretation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13102-022-00451-z

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

50 of 70 cited sources checked · 11 supported · 3 flagged · accuracy not yet measured

  • Premisecitation

    COVID-19 patients rapidly deteriorate to acute respiratory failure.

    “This is because the respiratory problems experienced by patients with COVID-19 significantly differ from other respiratory conditions (e.g., dry cough is common [4, 19]) and COVID-19 patients' rapid deterioration to acute respiratory failure [2–4].”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [2] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (Br Ed). 2020;395(10223):497–506. source

      The Discussion reports that patients with severe illness developed acute respiratory distress syndrome (ARDS), in some cases as soon as two days after admission. The Results show ARDS in 12 of 41 patients (29%). This supports rapid deterioration in a subset of the hospitalized cohort, but not the unqualified implication that COVID-19 patients generally deteriorate to acute respiratory failure. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [3] Ahmed T, Shah RJ, Rahim SEG, et al. Coronavirus Disease 2019 (COVID-19) complicated by acute respiratory distress syndrome: an internist’s perspective. Curēus. 2020;12(3):e7482. source

      The Case presentation reports that one patient developed acute hypoxic respiratory failure on day 2, and the Conclusions describe deterioration to moderate-to-severe ARDS within 48 hours. This supports rapid deterioration in the reported case, but the paper does not establish that COVID-19 patients generally deteriorate this way. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [4] Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. source

      The Results (Treatment and Complications; Clinical Outcomes, page not provided) report ARDS in 3.4% of patients and invasive mechanical ventilation in 2.3%. These findings support that some patients developed serious respiratory complications, but the cited passages do not establish rapid deterioration to acute respiratory failure as a general pattern among COVID-19 patients. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
  • Premisecitation

    At the time of writing, there is limited evidence about the effects of respiratory rehabilitation in the acute stage of COVID-19 treatment and cardio-respiratory recovery in patients with COVID-19.

    “At the time of writing, there is limited evidence about the effects of respiratory rehabilitation in the acute stage of COVID-19 treatment and cardio-respiratory recovery in patients with COVID-19 [15–18].”
    Quote in the paperSubstantial claim4 of 4 sources checked
    • cites [15] Lazzeri M, Lanza A, Bellini R, et al. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020. https://doi.org/10.4081/monaldi.2020.1285. source

      The Introduction (page not provided) anticipates that guidance on acute COVID-19 physiotherapy will need updating as further evidence on treatment approaches becomes available, which supports the claim that evidence was limited at the time. The paper does not specifically assess evidence about respiratory rehabilitation’s effects on cardio-respiratory recovery. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
    • cites [16] Zhao H-M, Xie Y-X, Wang C. Recommendations for respiratory rehabilitation in adults with COVID-19. Chin Med J. 2020;133:1595–602. source

      The section on severely and critically ill patients after discharge bases its recommendations partly on findings from SARS and MERS patients and clinical experience with ARDS, which supports the idea that direct COVID-19 recovery evidence was limited. The paper also urges caution about when to begin acute-stage rehabilitation. It does not explicitly assess how much evidence exists for rehabilitation’s effects on cardio-respiratory recovery or acute-stage treatment. (LLM, conf=0.72)

      Experimental — accuracy not yet measured
    • cites [17] Felten-Barentsz KM, van Oorsouw R, Klooster E, et al. Recommendations for hospital-based physical therapists managing patients with COVID-19. Phys Ther. 2020;100(9):1444–57. source

      The Pragmatic Methodology section (page unavailable) describes the evidence base for treating hospitalized patients with COVID-19 as rapidly evolving and says the recommendations draw partly on practice for other lung diseases and ICU patients. This supports the general point that COVID-specific evidence was limited at the time, but the paper does not specifically assess the evidence for respiratory rehabilitation’s effects during acute treatment or on cardiorespiratory recovery. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
    • cites [18] Abdullahi A. Safety and efficacy of chest physiotherapy in patients with COVID-19: a critical review. Front Med. 2020;7:454. source

      The Effects and Safety section says evidence for chest physiotherapy in COVID-19 was lacking, especially during the acute stage. The Post-Extubation and After Discharge section reports improvements in respiratory measures and endurance after rehabilitation, but does not establish a general lack of evidence about cardio-respiratory recovery. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Premisecitation

    The respiratory problems experienced by patients with COVID-19 significantly differ from other respiratory conditions (e.g., dry cough is common).

    “This is because the respiratory problems experienced by patients with COVID-19 significantly differ from other respiratory conditions (e.g., dry cough is common [4, 19]) and COVID-19 patients' rapid deterioration to acute respiratory failure [2–4].”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [4] Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. source

      The Discussion says some clinical characteristics distinguish COVID-19 from SARS, MERS, and seasonal influenza, but also says its characteristics mimic SARS. The Results report cough in 67.8% of patients; they do not specify dry cough or establish that respiratory problems differ significantly from other respiratory conditions generally. Page numbers are not available in our copy. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [19] Sun P, Lu X, Xu C, et al. Understanding of COVID-19 based on current evidence. J Med Virol. 2020;92(6):548–51. source
  • Premisecitation

    Respiratory rehabilitation may reduce psychological stress.

    “It may improve oxygen exchange, prevents the lungs from collapsing, reduce psychological stress and the need for artificial ventilation [10–12].”
    Quote in the paperNot a substantial claim1 of 3 sources checked
    • cites [10] Bott J, Blumenthal S, Buxton M, et al. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax. 2009;64(Suppl 1):i1–52. source
    • cites [11] Gigliotti F, Romagnoli I, Scano G. Breathing retraining and exercise conditioning in patients with chronic obstructive pulmonary disease (COPD): a physiological approach. Respir Med. 2003;97(3):197–204. source
    • cites [12] Hopper SI, Murray SL, Ferrara LR, Singleton JK. Effectiveness of diaphragmatic breathing for reducing physiological and psychological stress in adults: a quantitative systematic review. JBI Database System Rev Implement Rep. 2019;17(9):1855–76. source
  • Premisecitation

    Respiratory rehabilitation is crucial for the recovery of patients with viral pneumonia from COVID-19 during the acute and rehabilitation phases.

    “Respiratory rehabilitation is crucial for the recovery of patients with viral pneumonia from COVID-19 during the acute and rehabilitation phases [6, 9].”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [6] Yang L-L, Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chron Dis Transl Med. 2020;6(2):79–86. source
    • cites [9] Thomas P, Baldwin C, Bissett B, et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020;66(2):73–82. source

      The Purpose section calls early rehabilitation essential after the acute phase of respiratory distress for patients recovering from critical COVID-19 illness. The workforce-planning recommendations say respiratory physiotherapy may be indicated for patients with pneumonia, particularly when they have a weak cough or retained secretions. These passages do not establish that respiratory rehabilitation is crucial for all patients with COVID-19 viral pneumonia during both the acute and rehabilitation phases. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim. 29
  • May combine two claims. 27
  • Classified as probably not a substantial claim.

    Premisecitation

    Respiratory rehabilitation was recommended only for patients with moderate to severe COVID-19-related respiratory symptoms.

    “The study included only the patients with moderate to severe COVID-19-related respiratory symptoms because respiratory rehabilitation was recommended only for these patients according to previous literature [15–18].”
    Quote in the paperSubstantial claim4 of 4 sources checked
    • cites [15] Lazzeri M, Lanza A, Bellini R, et al. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020. https://doi.org/10.4081/monaldi.2020.1285. source

      The paper’s “Procedures NOT to be applied in the Acute Phase” section discourages several respiratory physiotherapy techniques during acute COVID-19, while its “7th ADVICE” discusses mobilization as sedation is reduced. Neither section states that respiratory rehabilitation is recommended only for patients with moderate-to-severe respiratory symptoms. Searches for that severity threshold and for recommendations concerning mild cases found no such passage in our copy. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
    • cites [16] Zhao H-M, Xie Y-X, Wang C. Recommendations for respiratory rehabilitation in adults with COVID-19. Chin Med J. 2020;133:1595–602. source

      The paper does not limit respiratory rehabilitation recommendations to patients with moderate to severe symptoms. Its section on mildly ill patients during hospitalization recommends breathing exercises and other activities (page not available in our copy). (LLM, conf=0.89)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
    • cites [17] Felten-Barentsz KM, van Oorsouw R, Klooster E, et al. Recommendations for hospital-based physical therapists managing patients with COVID-19. Phys Ther. 2020;100(9):1444–57. source

      The Scope and Treatment sections focus respiratory-support recommendations on hospitalized patients who are severely or critically ill with COVID-19. They do not recommend respiratory rehabilitation for patients with moderate symptoms as a group or state that it is recommended only for patients with moderate-to-severe respiratory symptoms. Page numbers are unavailable in our copy. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [18] Abdullahi A. Safety and efficacy of chest physiotherapy in patients with COVID-19: a critical review. Front Med. 2020;7:454. source

      The Introduction says chest physiotherapy can be used for patients with mild to moderate symptoms. The ‘Chest Physiotherapy During the Acute Period’ section also discusses its case-by-case use for patients with exudation and mild to moderate symptoms. This contradicts the claim that respiratory rehabilitation was recommended only for those with moderate to severe symptoms. Page numbers were not supplied. (LLM, conf=0.90)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Both scientific and anecdotal reports have highlighted the importance of breathing exercises for maintaining respiratory function [15-18].

    “Both scientific and anecdotal reports have highlighted the importance of breathing exercises for maintaining respiratory function [15–18].”
    Quote in the paperNot a substantial claim4 of 4 sources checked
    • cites [15] Lazzeri M, Lanza A, Bellini R, et al. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020. https://doi.org/10.4081/monaldi.2020.1285. source

      The section “Procedures NOT to be applied in the Acute Phase” says that diaphragmatic and pursed-lip breathing are not recommended for patients with COVID-19 during the acute phase because treatments must not add to the work of breathing. The paper therefore makes the contrary point for the acute setting it addresses; it does not establish that breathing exercises are unhelpful in other settings. (LLM, conf=0.85)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
    • cites [16] Zhao H-M, Xie Y-X, Wang C. Recommendations for respiratory rehabilitation in adults with COVID-19. Chin Med J. 2020;133:1595–602. source
    • cites [17] Felten-Barentsz KM, van Oorsouw R, Klooster E, et al. Recommendations for hospital-based physical therapists managing patients with COVID-19. Phys Ther. 2020;100(9):1444–57. source
    • cites [18] Abdullahi A. Safety and efficacy of chest physiotherapy in patients with COVID-19: a critical review. Front Med. 2020;7:454. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory tract disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

    “Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory tract disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1, 2].”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [1] World Health Organization. COVID-19 clinical management: living guidance, 25 January 2021. World Health Organization (2021). https://apps.who.int/iris/handle/10665/338882. Accessed 1 Jan 2022.

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [2] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (Br Ed). 2020;395(10223):497–506. source

      The Introduction identifies 2019-nCoV in lower respiratory tract samples from patients with pneumonia, supporting the claim that a novel coronavirus caused respiratory disease. The Discussion says evidence indicated human transmission but describes efficient human transmission as a concern, not an established finding; it does not support calling the disease “highly infectious.” The paper uses the earlier name 2019-nCoV rather than SARS-CoV-2. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The most common clinical presentation of severe COVID-19 is viral pneumonia featuring fever, cough, dyspnoea, hypoxemia, and bilateral infiltrates on chest radiographs.

    “Evidence shows that the most common clinical presentation of severe COVID-19 is viral pneumonia featuring fever, cough, dyspnoea, hypoxemia, and bilateral infiltrates on chest radiographs [2–4].”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites [2] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (Br Ed). 2020;395(10223):497–506. source

      The Results report pneumonia in all 41 patients, frequent fever and cough, dyspnoea in 12 of 13 ICU patients, and bilateral chest-radiograph involvement in all 13. The paper reports refractory hypoxaemia in only two patients and describes a small hospitalised cohort; it does not establish that the full combination is the most common presentation of severe COVID-19 generally. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [3] Ahmed T, Shah RJ, Rahim SEG, et al. Coronavirus Disease 2019 (COVID-19) complicated by acute respiratory distress syndrome: an internist’s perspective. Curēus. 2020;12(3):e7482. source

      The Case presentation (page unavailable) describes one patient with cough, shortness of breath, low oxygen saturation, later fever and hypoxia, and bilateral infiltrates on a subsequent chest X-ray. The Discussion (page unavailable) identifies the case as severe COVID-19 and lists severe pneumonia among reported complications. Neither section establishes that this combination is the most common presentation of severe COVID-19; the patient initially denied fever, and the first X-ray showed a right-sided opacity. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [4] Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. source

      The Results (Treatment and Complications; page not provided) report physician-diagnosed pneumonia in 99.4% of patients with severe disease. The Discussion identifies fever and cough as dominant symptoms and links compromised respiratory status to severity, but the available passages do not establish the full combination of dyspnoea, hypoxemia, and bilateral infiltrates on chest radiographs as the most common presentation. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Study design and conductcitation

    The sample of each group was large enough, and comparisons were not affected by the shape of the error distribution and no transformation was applied.

    “The sample of each group was large enough, and comparisons were not affected by the shape of the error distribution and no transformation was applied [27].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [27] Rochon J, Gondan M, Kieser M. To test or not to test: Preliminary assessment of normality when comparing two independent samples. BMC Med Res Methodol. 2012;12:81. source

      The Results (Strategy I; page unavailable) report that an unconditional two-sample t test maintained its nominal Type I error rate for the simulated normal, uniform, and exponential distributions. The paper does not establish that the citing study’s groups were large enough or that its comparisons were unaffected by their error distribution; it also does not address the citing authors’ decision not to transform their data. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim.

    Premisecitation

    Respiratory rehabilitation prevents the lungs from collapsing.

    “It may improve oxygen exchange, prevents the lungs from collapsing, reduce psychological stress and the need for artificial ventilation [10–12].”
    Quote in the paperSubstantial claim1 of 3 sources checked
    • cites [10] Bott J, Blumenthal S, Buxton M, et al. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax. 2009;64(Suppl 1):i1–52. source

      The pulmonary rehabilitation section reports benefits for exercise tolerance, breathlessness and quality of life, but does not say rehabilitation prevents lung collapse. The spinal cord injury section describes collapse as a possible consequence of impaired ventilation and secretion clearance; it does not establish the claimed preventive effect. Searches for atelectasis and lung collapse found no passage making that link. (LLM, conf=0.72)

      Experimental — accuracy not yet measured
    • cites [11] Gigliotti F, Romagnoli I, Scano G. Breathing retraining and exercise conditioning in patients with chronic obstructive pulmonary disease (COPD): a physiological approach. Respir Med. 2003;97(3):197–204. source
    • cites [12] Hopper SI, Murray SL, Ferrara LR, Singleton JK. Effectiveness of diaphragmatic breathing for reducing physiological and psychological stress in adults: a quantitative systematic review. JBI Database System Rev Implement Rep. 2019;17(9):1855–76. source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Severe respiratory symptoms can cause respiratory failure (ARDS), which can lead to death unless promptly managed using ventilation at ICU.

    “As mentioned before, severe respiratory symptoms can cause respiratory failure (ARDS), which can lead to death unless promptly managed using ventilation at ICU [2, 3, 6].”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites [2] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (Br Ed). 2020;395(10223):497–506. source

      The Discussion reports that severely ill patients developed ARDS and required ICU admission and oxygen therapy; the Results report mechanical ventilation in four patients and six deaths. The paper does not establish that prompt ICU ventilation prevents death or that death follows unless it is provided. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [3] Ahmed T, Shah RJ, Rahim SEG, et al. Coronavirus Disease 2019 (COVID-19) complicated by acute respiratory distress syndrome: an internist’s perspective. Curēus. 2020;12(3):e7482. source

      The Case presentation and Discussion describe acute hypoxic respiratory failure progressing to moderate-to-severe ARDS, followed by intubation and mechanical ventilation in the ICU. The Discussion also reports that ARDS can have fatal outcomes. The paper does not establish that prompt ICU ventilation prevents death; the patient remained critically ill with a poor prognosis after ventilation. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [6] Yang L-L, Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chron Dis Transl Med. 2020;6(2):79–86. source

      The section ‘Necessity of pulmonary rehabilitation for patients with COVID-19’ says severe cases can rapidly progress to ARDS. The ‘Pulmonary rehabilitation guidelines’ section says life-saving measures should take priority for unstable severe or critical cases, but our copy does not say that ARDS leads to death unless promptly treated with ventilation in an ICU. Page numbers are unavailable in our copy. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim.

    Premisecitation

    A recent scoping review found that respiratory rehabilitation appears to be useful in COVID-19 survivors.

    “The review found that respiratory rehabilitation appears to be useful in COVID-19 survivors, and respiratory rehabilitation starting already in a hospital may lead to improved overall respiratory function and reduced hospital stay.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [13] Siddiq MAB, Rathore FA, Clegg D, Rasker JJ. Pulmonary rehabilitation in COVID-19 patients: a scoping review of current practice and its application during the pandemic. Turk J Phys Med Rehabil. 2020;66(4):480–94. source
  • Classified as probably not a substantial claim.

    Premisecitation

    The authors of the scoping review concluded a paucity of high-quality research on respiratory rehabilitation in COVID-19.

    “However, the authors concluded a paucity of high-quality research on this topic [13].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [13] Siddiq MAB, Rathore FA, Clegg D, Rasker JJ. Pulmonary rehabilitation in COVID-19 patients: a scoping review of current practice and its application during the pandemic. Turk J Phys Med Rehabil. 2020;66(4):480–94. source
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Respiratory rehabilitation starting already in a hospital may lead to improved overall respiratory function and reduced hospital stay.

    “The review found that respiratory rehabilitation appears to be useful in COVID-19 survivors, and respiratory rehabilitation starting already in a hospital may lead to improved overall respiratory function and reduced hospital stay.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [13] Siddiq MAB, Rathore FA, Clegg D, Rasker JJ. Pulmonary rehabilitation in COVID-19 patients: a scoping review of current practice and its application during the pandemic. Turk J Phys Med Rehabil. 2020;66(4):480–94. source

      The Discussion recommends starting pulmonary rehabilitation during a COVID-19 patient's inpatient stay and describes potential respiratory benefits. But its evidence for a shorter hospital stay comes from COPD patients, and it explicitly says the outcomes of these interventions in COVID-19 cases remain to be determined. Page numbers were not available in our copy. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Breathing exercise improves respiratory muscle function, ribcage flexibility, and gas exchange, and may decrease blood pressure, respiratory rate, and stress.

    “The physiological rationale behind the progress might be that breathing exercise improves respiratory muscle function, ribcage flexibility, gas exchange, and may decrease blood pressure, respiratory rate, and stress [11, 12, 28, 29]; consequently, helping patients with COVID-19 to manage their respiratory symptoms.”
    Quote in the paperSubstantial claim1 of 4 sources checked
    • cites [11] Gigliotti F, Romagnoli I, Scano G. Breathing retraining and exercise conditioning in patients with chronic obstructive pulmonary disease (COPD): a physiological approach. Respir Med. 2003;97(3):197–204. source
    • cites [12] Hopper SI, Murray SL, Ferrara LR, Singleton JK. Effectiveness of diaphragmatic breathing for reducing physiological and psychological stress in adults: a quantitative systematic review. JBI Database System Rev Implement Rep. 2019;17(9):1855–76. source
    • cites [28] McIlwaine M, Bradley J, Elborn JS, et al. Personalising airway clearance in chronic lung disease. Eur Respir Rev. 2017;26(143):160086. source

      The ‘Active cycle of breathing techniques’ section (page unavailable) says thoracic expansion exercises and a breath hold improve ventilation distribution and alveolar gas mixing. That supports a respiratory-ventilation rationale, but it does not establish improved respiratory muscle function or ribcage flexibility, improved gas exchange itself, or reductions in blood pressure, respiratory rate, or stress. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [29] Elad D, Wolf M, Keck T. Air-conditioning in the human nasal cavity. Respir Physiol Neurobiol. 2008;163(1–3):121–7. source
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Premisecitation

    Respiratory rehabilitation should be considered when there are no signs of progressive deterioration and patients are hospitalised, as recommended by Chinese, the Netherlands, Italian, and UK rehabilitation professionals [6, 10, 15, 17, 33].

    “Respiratory rehabilitation should be considered when there are no signs of progressive deterioration and patients are hospitalised, as recommendations by Chinese, the Netherlands, Italian, and UK rehabilitation professionals [6, 10, 15, 17, 33].”
    Quote in the paperNot a substantial claim5 of 5 sources checked
    • cites [6] Yang L-L, Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chron Dis Transl Med. 2020;6(2):79–86. source
    • cites [10] Bott J, Blumenthal S, Buxton M, et al. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax. 2009;64(Suppl 1):i1–52. source

      The “Pulmonary rehabilitation peri-and postexacerbation” section recommends considering rehabilitation during an exacerbation for patients with COPD and describes inpatient rehabilitation during admission. It does not give absence of progressive deterioration as a criterion or extend that recommendation to hospitalised patients generally. The passages provided do not give a page number. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [15] Lazzeri M, Lanza A, Bellini R, et al. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020. https://doi.org/10.4081/monaldi.2020.1285. source

      In the section on preventing physical disability (page unavailable), the Italian position paper recommends early mobilization once the patient's condition is clinically stable; its Conclusions describe physiotherapy for hospitalized patients with severe COVID-19. This supports considering mobilization during hospitalization when the patient is stable, but it does not expressly recommend respiratory rehabilitation as a whole under that condition. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
    • cites [17] Felten-Barentsz KM, van Oorsouw R, Klooster E, et al. Recommendations for hospital-based physical therapists managing patients with COVID-19. Phys Ther. 2020;100(9):1444–57. source

      The Treatment recommendations (Section 2: Patient Is Severely Ill and Admitted to the COVID Ward; page unavailable) recommend respiratory support for hospitalized patients with COVID-19, and the Abstract identifies the paper as Dutch guidance. The passages do not make an absence of progressive deterioration a condition for considering respiratory rehabilitation. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [33] Wang TJ, Chau B, Lui M, et al. Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19. Am J Phys Med Rehabil. 2020;99(9):769–74. source

      The Introduction (page unavailable) supports considering pulmonary rehabilitation for hospitalized patients, with safety screening that excludes patients with substantial chest-image progression and other signs of instability. It does not say that an absence of progressive deterioration is sufficient on its own, or identify this recommendation as one made collectively by Chinese, Dutch, Italian, and UK rehabilitation professionals. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • Rests on an assumption: There is a high respiratory impairment burden following the acute phase of COVID-19.
  • May combine two claims.

    Premisecitation

    Abdominal chest imaging and severe impairment to pulmonary diffusion capacities was reported in COVID-19 patients recovered from severe illness [32].

    “Abdominal chest imaging, and severe impairment to pulmonary diffusion capacities was reported in COVID-19 patients recovered from severe illness [32].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [32] Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–32. source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    It has previously been recommended that breathing exercises be stopped for chest pain, palpations, and dizziness and be stopped if SpO2 does not recover even with rest and oxygen supplementation [33].

    “It has previously been recommended that breathing exercises be stopped for chest pain, palpations, and dizziness and be stopped if SpO2 does not recover even with rest and oxygen supplementation [33].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [33] Wang TJ, Chau B, Lui M, et al. Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19. Am J Phys Med Rehabil. 2020;99(9):769–74. source

      The Introduction recommends stopping rehabilitation exercises for chest pain, palpitations, or dizziness. It also recommends stopping pulmonary rehabilitation or breathing exercises when SpO2 does not recover with rest and oxygen supplementation, but specifies an additional condition: the patient cannot maintain a Borg dyspnea score below 4. The claim omits that condition. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Patients can be in all suitable positions including prone, side-lying, upright, supine, and guided by the location of consolidations seen on imaging or found on examination [31].

    “However, the patients can be in all suitable positions including prone, side-lying, upright, supine, and guided by the location of consolidations seen on imaging or found on examination [31].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [31] Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. source

      The Results section, “Imaging, complications, and outcomes” (page unavailable), reports chest X-ray findings but does not discuss patient positioning. Searches for prone, side-lying, upright, and supine positions, and for positioning guided by consolidation location or examination, found no supporting passage in our copy. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    In patients with COVID-19, low blood oxygen levels are associated with rapid deterioration to acute respiratory distress or failure, leading to death unless it is managed immediately [2-4].

    “In patients with COVID-19, low blood oxygen levels are associated with rapid deterioration to acute respiratory distress or failure, leading to death unless it is managed immediately [2–4].”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [2] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (Br Ed). 2020;395(10223):497–506. source

      The Discussion (page not provided) says severe patients developed ARDS, sometimes within two days of admission, and six of 41 patients died. The Results also report refractory hypoxaemia in two patients who received salvage therapy. The paper does not establish that low oxygen levels predict rapid deterioration or that death follows unless they are managed immediately. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [3] Ahmed T, Shah RJ, Rahim SEG, et al. Coronavirus Disease 2019 (COVID-19) complicated by acute respiratory distress syndrome: an internist’s perspective. Curēus. 2020;12(3):e7482. source

      The Case presentation and Conclusions describe one patient whose hypoxia worsened rapidly and who developed respiratory failure and moderate-to-severe ARDS within 48 hours. The paper does not establish this as a general association in patients with COVID-19 or show that death follows unless the condition is managed immediately; the patient remained critically ill in the ICU at the time of reporting. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [4] Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. source

      The Discussion links compromised respiratory status on admission to worse outcomes, and the Results report ARDS and deaths among patients with COVID-19. The paper does not establish that low blood oxygen causes rapid progression to respiratory failure or that death follows unless it is managed immediately. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    A forced expiratory technique like huffing and coughing increases the linear velocity of the expiratory airflow and propels secretions, which helps in airway clearance [28].

    “A forced expiratory technique like huffing and coughing increases the linear velocity of the expiratory airflow and propels secretions, which help in airways clearance [28].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [28] McIlwaine M, Bradley J, Elborn JS, et al. Personalising airway clearance in chronic lung disease. Eur Respir Rev. 2017;26(143):160086. source
  • May combine two claims.

    Premisecitation

    Suitable positioning may enhance ventilation, perfusion, oxygenation, and mobilization of tracheobronchial secretions via gravitational effects [23, 30].

    “Suitable positioning may be used to enhance ventilation, perfusion, oxygenation, and mobilization of tracheobronchial secretions via gravitational effects [23, 30].”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [23] Schifino G, de Grauw AJ, Daniele F, et al. Effects of prone and lateral position in non-intubated patients with 2019 Novel Coronavirus (COVID-19) pneumonia. Pulmonology. 2021;27(2):167–71. source

      In the paper’s main text (page unavailable), prone and lateral positioning are associated with improved oxygenation and breathing pattern, and the authors describe gravity-related changes in ventilation–perfusion matching. The paper does not address mobilization of tracheobronchial secretions, so it supports only part of the cited sentence. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [30] Cullen DL, Rodak B. Clinical utility of measures of breathlessness. Respir Care. 2002;47(9):986–93. source
  • May combine two claims.

    Findingown data

    The intervention group included 79 patients (69.6% men, mean age 50.1 ± 10.5 years), and the control group included 58 patients (62.1% men, mean age 51.5 ± 10.4 years).

    “The intervention group included 79 patients (69.6% men, mean age 50.1 ± 10.5 years), and the control group included 58 patients (62.1% men, mean age 51.5 ± 10.4 years).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    At baseline, there were no significant differences (P > 0.05) in mean SpO2, need for oxygen, respiratory rate, or heart rate between the intervention and control groups.

    “At the baseline, no significant differences were found (P > 0.05) in the mean values of SpO2, the need for oxygen, respiratory rate, and heart rate between the intervention and the control group (Table 2).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The COVID-19 patients included in the intervention group were sufficiently stable during the study period, and only three patients needed admission to the ICU after the intervention started.

    “It should be noted that the COVID-19 patients included in the intervention group in our study were sufficiently stable during the study period, and only three patients needed to admit to the ICU after the intervention started.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    Both groups received a standard protocol for data collection, such as the same types of equipment, the same time of the day, and ensured comparability among the measures in the respective hospital.

    “Both groups (intervention and control) received a standard protocol for data collection, such as the same types of equipment, the same time of the day, and ensure comparability among the measures in the respective hospital.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductown data

    The sociodemographic and hematological data, and presence of comorbidity did not differ statistically between the intervention and control groups (P > 0.05), except total White Blood Cell count was higher in the intervention group compared to the control group (P = 0.04).

    “The sociodemographic- and hematological data, and presence of comorbidity did not differ statistically between the intervention and the control groups (P > 0.05), except for the total White Blood Cell (WBC) count that was found higher in the intervention group, compared to the control group (P = 0.04).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    A priori power analysis for a repeated-measures analysis of variance with two repeated-measures showed that a total of 108 participants would be required to get a statistical power (1 − β err prob) of 80%.

    “A priori power analysis for a repeated-measures analysis of variance with two repeated-measures showed that a total of 108 participants would require to get a statistical power (1 − β err prob) of 80%.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    A total of 79 persons in the intervention and 58 persons in the control group were analysed at 4-day follow-up, and 64 persons in the intervention and 50 persons in the control group were analysed at 7-day follow-up.

    “A total of 79 persons in the intervention and 58 persons in the control group were analysed at 4-day of follow-up, and 64 persons in the intervention and 50 persons in the control group were analysed at 7-day of follow-up (Fig. 1).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    A physiotherapist supervised each breathing exercise session.

    “A physiotherapist supervised each breathing exercise session”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    Respiratory rehabilitation improves the physical and psychological symptoms of lung diseases such as chronic obstructive pulmonary disease (COPD).

    “Respiratory rehabilitation improves the physical and psychological symptoms of lung diseases such as chronic obstructive pulmonary disease (COPD) [11].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [11] Gigliotti F, Romagnoli I, Scano G. Breathing retraining and exercise conditioning in patients with chronic obstructive pulmonary disease (COPD): a physiological approach. Respir Med. 2003;97(3):197–204. source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    Among all sessions, at least three sessions were delivered by direct supervision of the physiotherapist; the rest were delivered with the assistance of a trained nurse or nursing assistant and were recorded in an activity log.

    “Among all sessions, at least three sessions were delivered by direct supervision of the Physiotherapist. The rest of the sessions were delivered with the assistance of a trained nurse or nursing assistant and were recorded in an activity log.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationnone given

    These results should be considered preliminary until they are replicated in larger samples in different settings.

    “These results should be considered preliminary until they are replicated in larger samples in different settings.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    For the present study, outcomes were measured when a patient was in a complete resting position at around 10.00 am, at baseline, and 4 days and 7 days after baseline, and measurements were taken at least 30 min after any breathing exercise session for the intervention group.

    “For the present study, we measured the outcomes when a patient was in a complete resting position at around 10.00 am, at baseline, and 4 days and 7 days after the baseline assessment for the intervention and the control group. However, the measurements were taken at least 30 min after any breathing exercise session for the intervention group.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The elected hospital for intervention consisted of a well-trained physiotherapists' team in the breathing exercise intervention.

    “The elected hospital for intervention consisted of a well-trained physiotherapists' team in the breathing exercise intervention.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    The selected hospitals had equally trained qualified health care workers (e.g., nurses, physicians, or physiotherapists) for patients' assessment and data collection.

    “We selected all these hospitals based on the criteria that they have equally trained qualified health care workers (e.g., nurses, physicians, or physiotherapists) for patients' assessment and data collection.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Study design and conductnone given

    These results should be considered preliminary until they are replicated in larger samples in various settings.

    “These results should be considered preliminary until they are replicated in larger samples in various settings.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    A systematic review of randomized controlled trials and two quasi-experimental studies in adults suggests that diaphragmatic breathing may decrease blood pressure, respiratory rate, and psychological stress [12].

    “A systematic review of randomized controlled trials and two quasi-experimental studies in adults suggests that diaphragmatic breathing may decrease blood pressure, respiratory rate, and psychological stress [12].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [12] Hopper SI, Murray SL, Ferrara LR, Singleton JK. Effectiveness of diaphragmatic breathing for reducing physiological and psychological stress in adults: a quantitative systematic review. JBI Database System Rev Implement Rep. 2019;17(9):1855–76. source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Inspiration through the nose facilitates recruitment of the diaphragm and improves humidification [29].

    “Inspiration through the nose should be encouraged to facilitate the recruitment of the diaphragm and improve humidification [29].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [29] Elad D, Wolf M, Keck T. Air-conditioning in the human nasal cavity. Respir Physiol Neurobiol. 2008;163(1–3):121–7. source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductreasoning

    Study participants were recruited from four tertiary hospitals in Bangladesh; the intervention group from one hospital, and the control group from the other three hospitals. Therefore, resource availability might differ between hospitals.

    “Study participants were recruited from four tertiary hospitals from Bangladesh; the intervention group from one hospital, and the control group from the other three hospitals. Therefore, resource availability might differ between hospitals.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    Patients with COVID-19 were not excluded based on pre-specified comorbidities (e.g., COPD), so the findings apply to similar populations.

    “Further patients with COVID-19 were not excluded based on pre-specified comorbidities (e.g., COPD). Thus, our findings apply to similar populations.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Typically, a non-productive cough is associated with COVID-19; productive coughing may appear at a later stage [19].

    “Typically, a non-productive cough is associated with COVID-19; productive coughing may appear at a later stage [19].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [19] Sun P, Lu X, Xu C, et al. Understanding of COVID-19 based on current evidence. J Med Virol. 2020;92(6):548–51. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    No specific information about the number of interventions was collected between the 5-day and 7-day follow-up, as the intervention was varied or reduced based on patients' needs during this follow-up period.

    “Another limitation of our study is that no specific information about the number of interventions was collected between the 5-day and 7-day of follow-up, as the intervention was varied or reduced based on patients' needs during this follow-up period.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    Breathing exercises, as part of respiratory rehabilitation, improved respiratory parameters (SpO2, respiratory rate, heart rate, and need for oxygen) in patients hospitalised with COVID-19, with greater improvement in the intervention group than in the control group.

    “One of the key findings of the present study was that SpO2, respiratory rate, and heart rate improved in patients with COVID-19 who received breathing exercise while reducing their need for oxygen therapy.”
    • Also stated in: § Discussion · boosted
      “The results supported our original hypothesis that respiratory parameters would improve in both intervention and control groups, with the intervention group demonstrating more significant improvements compared to the control group.”
    • Also stated in: § Conclusions · plain
      “Breathing exercise as a part of respiratory rehabilitation improved respiratory parameters in patients hospitalised with COVID-19.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductcitation

    Standardised care was provided to all patients according to the National Guidelines on Clinical Management of COVID-19 [22], and a standard protocol for data collection was followed to ensure comparability among measures collected in different hospitals.

    “However, the standardised care was provided to all patients according to the National Guidelines on Clinical Management of COVID-19 [22], and we followed a standard protocol for data collection (e.g., same instrument, same time of the day, same order) to ensure comparability among the measures collected in different hospitals.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [22] National Guidelines on Clinical Management of Coronavirus Disease 2019 (Covid-19). Disease Control Division Directorate General of Health Services Ministry of Health & Family Welfare Government of the People's Republic of Bangladesh, 2020.

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Study design and conductnone given

    The sample was representative of both sexes and sociodemographic background, with broad age groups (18-70 years).

    “Another strength is the representative sample size from both sexes and sociodemographic background (e.g., educational level, employment), with broad age groups (18–70 years).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing). May combine two claims.

    Interpretationreasoning

    Health care systems are overwhelmed in many countries; respiratory rehabilitation provides some respite.

    “Health care systems are overwhelmed in many countries; respiratory rehabilitation thus provides some respite.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Respiratory rehabilitation is non-invasive, safe, easy to implement, and cost-effective.
    • Rests on an assumption: Health care systems are overwhelmed in many countries.
43 of 43
  • The paper relies on this without support.

    The availability of health resources to treat COVID-19 patients in low-resource settings may be limited.

    “Also, the availability of health resources to treat COVID-19 patients in low-resource settings may be limited.”
  • The paper relies on this without support.

    The impact of short-term respiratory rehabilitation on respiratory parameters in COVID-19 patients in resource-poor settings is not previously established.

    “As a cost-effective intervention, the impact of short-term respiratory rehabilitation on respiratory parameters in COVID-19 patients in resource-poor settings is not previously established.”
  • The paper relies on this without support.

    Breathing exercise is a non-invasive and cost-effective respiratory rehabilitation intervention.

    “As a non-invasive and cost-effective respiratory rehabilitation intervention, breathing exercise can be a valuable tool for a health care system overwhelmed by the COVID-19 pandemic.”
  • The paper relies on this without support.

    This is the first study to investigate the short-term effect of breathing exercises on respiratory recovery in patients with COVID-19 using a quasi-experimental study design.

    “To the best of our knowledge, this is the first study to investigate the short-term effect of breathing exercises on respiratory recovery in patients with COVID-19, using a quasi-experimental study design.”
  • The paper relies on this without support.

    Respiratory rehabilitation is non-invasive, safe, easy to implement, and cost-effective.

    “Respiratory rehabilitation is non-invasive, safe, and easy to implement, and cost-effective.”
  • The paper relies on this without support.

    Health care systems are overwhelmed in many countries.

    “Health care systems are overwhelmed in many countries; respiratory rehabilitation thus provides some respite.”
  • The paper relies on this without support.

    There is a high respiratory impairment burden following the acute phase of COVID-19.

    “Given the high respiratory impairment burden following the acute phase of COVID-19, patients should be referred early to a respiratory rehabilitation programme, particularly those admitted to a hospital.”
  • The paper relies on this without support.

    SARS-CoV-2 is highly contagious.

    “However, given the highly contagious nature of the SARS-CoV-2, a robust respiratory rehabilitation plan must be in place to make optimal use of a limited rehabilitation workforce and reduce risk to health professionals.”
8 of 8

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • White blood cell difference is described in the wrong direction

    Minor

    The text says the intervention group had the higher white blood cell count, but Table 1 reports 8260.8 for the intervention group and 9818.9 for the control group.

1 of 1

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

  • Cites a retracted work: 10.1016/s0140-6736(20)32656-8

    Info

    The cited work was retracted on 2023-06-09 (notice 10.1016/s0140-6736(23)01175-3), not before this paper was published (2022-04-05).

    Cited work 10.1016/s0140-6736(20)32656-8 · retracted 2023-06-09 · notice 10.1016/s0140-6736(23)01175-3 · this paper published 2022-04-05

1 of 1

Cites

1 retracted

Flagged first, then by citations

2 of the 36 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kader, M., Hossain, M. A., Reddy, V., Perera, N. K. P., & Rashid, M.
Affiliations
  • Karolinska Institutet (SE)
  • Linköping University (SE)
  • University of Gävle (SE)
Corresponding author
Kader, Manzur
Venue
BMC Sports Science, Medicine and Rehabilitation
Published
2022-04-05
Volume
14
Issue
1
Pages
60-60
ISSN
2052-1847 (ISSN-L)
OpenAlex
W4225853671
Cited by
33
References
36
Citations by year
2026: 1 · 2025: 6 · 2024: 10 · 2023: 12 · 2022: 2 · 2021: 2
FWCI
3.39
Type
journal article
Language
en
Open access
Locations
  • BMC Sports Science Medicine and Rehabilitation (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • DiVA (Linkoping University) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Greater South Information System
Funders
Karolinska Institute
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
Keywords
COVID-19 pandemic, breathing exercises, pulmonary rehabilitation, respiratory recovery, acute respiratory failure, diaphragmatic breathing, huffing, forced expiratory technique, oxygen saturation, oxygen therapy, respiratory rate, heart rate, non-pharmacological treatment, cough, deep breathing, respiratory control, SARS-CoV-2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-17.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-17.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review